RxSight appoints Shweta Maniar and Dr. Tamara Fountain to board; expands to nine members

RxSight, Inc.

Board expanded from 7 to 9; Maniar (Google Cloud) and Dr. Fountain (ophthalmologist) effective Dec 31, 2021 and Jan 1, 2022.
Maniar serves on Governance/Nominating Committee; receives $45k annual retainer, $5k committee fee, initial RSUs valued at $217,500.
Dr. Fountain, 2021 President of American Academy of Ophthalmology, serves on Audit Committee; receives no compensation during 2022 per AAO policy.
Outside Director Compensation Policy updated: annual cash retainer raised from $40k to $45k; initial RSU award increased from $125k to $217,500.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Tamara Fountain, M.D.

Director

RXST · RxSight, Inc.

Effective: 2022-01-01
Filed: January 4, 2022, 6:59 PM ET

On December 29, 2021 the board of directors (the “Board”) of RxSight, Inc. (the “Company”) increased the number of its authorized directors from seven to nine, and appointed Shweta Singh Maniar and Tamara Fountain, M.D. to fill the two newly created openings on the Board, effective December 31, 2021 and January 1, 2022, respectively.

Appointed

Shweta Singh Maniar

Director

RXST · RxSight, Inc.

Effective: 2021-12-31
Filed: January 4, 2022, 6:59 PM ET

On December 29, 2021 the board of directors (the “Board”) of RxSight, Inc. (the “Company”) increased the number of its authorized directors from seven to nine, and appointed Shweta Singh Maniar and Tamara Fountain, M.D. to fill the two newly created openings on the Board, effective December 31, 2021 and January 1, 2022, respectively.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Tamara Fountain, M.D. was appointed as Director at RxSight, Inc..

Action: appointed
Role: Director

Exact text from the filing

On December 29, 2021 the board of directors (the “Board”) of RxSight, Inc. (the “Company”) increased the number of its authorized directors from seven to nine, and appointed Shweta Singh Maniar and Tamara Fountain, M.D. to fill the two newly created openings on the Board, effective December 31, 2021 and January 1, 2022, respectively.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Shweta Singh Maniar was appointed as Director at RxSight, Inc..

Action: appointed
Role: Director

Exact text from the filing

On December 29, 2021 the board of directors (the “Board”) of RxSight, Inc. (the “Company”) increased the number of its authorized directors from seven to nine, and appointed Shweta Singh Maniar and Tamara Fountain, M.D. to fill the two newly created openings on the Board, effective December 31, 2021 and January 1, 2022, respectively.

View on SEC.gov

RxSight, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-22-000038

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.